Register by January 21st and SAVE up to $400!
Coverage Includes:
Leveraging Knowledge Management Tools for Matching Internal Expertise to External Opportunities
Different Information Sourcing Models in Response to Biotech/Pharma R&D Restructuring
Implications of Potential Patentability Changes on Biologicals
Anticipating the Evolving Knowledge Needs of Senior Management
Integrating Development Pipelines from Collaborations and Partnerships into Business Intelligence
Placing More Focus on Nascent Stage Discovery Assessment
Using Technology Landscaping to Source Biopharmaceutical Partners
Ways to Incorporate Intellectual Property into Biotech/Pharma Business Intelligence Programs
Organizing Outside Groups to Generate Objective Discovery Intelligence
Using Technology Landscaping to Source Biopharmaceutical Partners
Barry Brager, Founder and Managing Partner, Perception Partners
The Role of Intellectual Property in Competitive Intelligence Programs Targeting the Bio-Pharma Field
Bradley Olson, Counsel/Patent Attorney, Intellectual Property Group, Dickstein Shapiro LLP
PharmaConnect: Connecting Awareness of the External World with Internal Expertise and Analysis
Bryan Takasaki, Ph.D., IS Informatics Science Director, R&D Information, AstraZeneca
Using Objective Outside Groups to Gain Competitive Advantage
Jack Peregrim, President, Management, PARAGON Development
Patentability of Biologicals–Implications for Industry
Chris Holman, Ph.D., J.D., Associate Professor, Law, University of Missouri-Kansas City School of Law
Role of Knowledge Management in Searching for Global Opportunities
Michael R. Myers, Ph.D., Senior Director, Global External R&D, Eli Lilly (tentative)
Talk Title to be Announced
Daniel R. Pascheles, Ph.D., Vice President, Global Competitive Intelligence, Merck (invited)
Limited Speaking Opportunities Still Available:
Those who wish to present their knowledge and expertise to their colleagues are asked to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.
If you are interested in presenting, please submit a speaking proposal for review.
|